Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 378

1.

Effectiveness of anti-osteoporotic treatment after successful parathyroidectomy for primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial.

Niederle MB, Foeger-Samwald U, Riss P, Selberherr A, Scheuba C, Pietschmann P, Niederle B, Kerschan-Schindl K.

Langenbecks Arch Surg. 2019 Aug 26. doi: 10.1007/s00423-019-01815-9. [Epub ahead of print]

PMID:
31451913
2.

The determination of real fluid requirements in laparoscopic resection of pheochromocytoma using minimally invasive hemodynamic monitoring: a prospectively designed trial.

Niederle MB, Fleischmann E, Kabon B, Niederle B.

Surg Endosc. 2019 Apr 11. doi: 10.1007/s00464-019-06777-z. [Epub ahead of print]

PMID:
30976898
3.

Surgical therapy of adrenal tumors: guidelines from the German Association of Endocrine Surgeons (CAEK).

Lorenz K, Langer P, Niederle B, Alesina P, Holzer K, Nies C, Musholt T, Goretzki PE, Rayes N, Quinkler M, Waldmann J, Simon D, Trupka A, Ladurner R, Hallfeldt K, Zielke A, Saeger D, Pöppel T, Kukuk G, Hötker A, Schabram P, Schopf S, Dotzenrath C, Riss P, Steinmüller T, Kopp I, Vorländer C, Walz MK, Bartsch DK.

Langenbecks Arch Surg. 2019 Jun;404(4):385-401. doi: 10.1007/s00423-019-01768-z. Epub 2019 Apr 1.

PMID:
30937523
4.

Intertumor heterogeneity in 60 pancreatic neuroendocrine tumors associated with multiple endocrine neoplasia type 1.

Selberherr A, Koperek O, Riss P, Scheuba C, Niederle MB, Kaderli R, Perren A, Niederle B.

Orphanet J Rare Dis. 2019 Feb 22;14(1):54. doi: 10.1186/s13023-019-1034-4.

5.

Neuroendocrine Liver Metastasis-a Specific Set of Markers to Detect Primary Tumor Sites.

Selberherr A, Koperek O, Riss P, Scheuba C, Kaderli R, Perren A, Niederle B.

Endocr Pathol. 2019 Mar;30(1):31-34. doi: 10.1007/s12022-018-9558-z.

6.

Calcium-stimulated calcitonin - The "new standard" in the diagnosis of thyroid C-cell disease - clinically relevant gender-specific cut-off levels for an "old test".

Niederle MB, Scheuba C, Gessl A, Li S, Koperek O, Bieglmayer C, Riss P, Selberherr A, Niederle B.

Biochem Med (Zagreb). 2018 Oct 15;28(3):030710. doi: 10.11613/BM.2018.030710.

7.

Medullary Thyroid Carcinoma: Do Ultrasonography and F-DOPA-PET-CT Influence the Initial Surgical Strategy?

Brammen L, Niederle MB, Riss P, Scheuba C, Selberherr A, Karanikas G, Bodner G, Koperek O, Niederle B.

Ann Surg Oncol. 2018 Dec;25(13):3919-3927. doi: 10.1245/s10434-018-6829-3. Epub 2018 Oct 10.

8.

[Update of the S2k guidelines : Surgical treatment of benign thyroid diseases].

Musholt TJ, Bockisch A, Clerici T, Dotzenrath C, Dralle H, Goretzki PE, Hermann M, Holzer K, Karges W, Krude H, Kussmann J, Lorenz K, Luster M, Niederle B, Nies C, Riss P, Schabram J, Schabram P, Schmid KW, Simon D, Spitzweg C, Steinmüller T, Trupka A, Vorländer C, Weber T, Bartsch DK; Leitliniengruppe der CAEK.

Chirurg. 2018 Sep;89(9):699-709. doi: 10.1007/s00104-018-0653-y. Review. German.

PMID:
29876616
9.

MAFA missense mutation causes familial insulinomatosis and diabetes mellitus.

Iacovazzo D, Flanagan SE, Walker E, Quezado R, de Sousa Barros FA, Caswell R, Johnson MB, Wakeling M, Brändle M, Guo M, Dang MN, Gabrovska P, Niederle B, Christ E, Jenni S, Sipos B, Nieser M, Frilling A, Dhatariya K, Chanson P, de Herder WW, Konukiewitz B, Klöppel G, Stein R, Korbonits M, Ellard S.

Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1027-1032. doi: 10.1073/pnas.1712262115. Epub 2018 Jan 16.

10.

Surgical Treatment of Small Intestinal Neuroendocrine Tumors G1/G2.

Selberherr A, Niederle MB, Niederle B.

Visc Med. 2017 Oct;33(5):340-343. doi: 10.1159/000477786. Epub 2017 Oct 6. Review.

11.

In Reply: Prophylactic "First-Step" Central Neck Dissection (Level 6) Does not Increase Morbidity After (Total) Thyroidectomy.

Selberherr A, Riss P, Scheuba C, Niederle B.

Ann Surg Oncol. 2017 Dec;24(Suppl 3):633. doi: 10.1245/s10434-017-6153-3. Epub 2017 Oct 27. No abstract available.

PMID:
29079925
12.

Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma.

Schlumberger M, Elisei R, Müller S, Schöffski P, Brose M, Shah M, Licitra L, Krajewska J, Kreissl MC, Niederle B, Cohen EEW, Wirth L, Ali H, Clary DO, Yaron Y, Mangeshkar M, Ball D, Nelkin B, Sherman S.

Ann Oncol. 2017 Nov 1;28(11):2813-2819. doi: 10.1093/annonc/mdx479.

13.

Primary hyperparathyroidism: Dynamic postoperative metabolic changes.

Kaderli RM, Riss P, Geroldinger A, Selberherr A, Scheuba C, Niederle B.

Clin Endocrinol (Oxf). 2018 Jan;88(1):129-138. doi: 10.1111/cen.13476. Epub 2017 Oct 1.

PMID:
28906021
14.

The impact of vitamin D status on hungry bone syndrome after surgery for primary hyperparathyroidism.

Kaderli RM, Riss P, Dunkler D, Pietschmann P, Selberherr A, Scheuba C, Niederle B.

Eur J Endocrinol. 2018 Jan;178(1):1-9. doi: 10.1530/EJE-17-0416. Epub 2017 Sep 6.

PMID:
28877925
15.

Factors influencing pre-operative urinary calcium excretion in primary hyperparathyroidism.

Kaderli RM, Riss P, Geroldinger A, Selberherr A, Scheuba C, Niederle B.

Clin Endocrinol (Oxf). 2017 Jul;87(1):97-102. doi: 10.1111/cen.13348. Epub 2017 May 5.

PMID:
28383779
16.

ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours.

Partelli S, Bartsch DK, Capdevila J, Chen J, Knigge U, Niederle B, Nieveen van Dijkum EJM, Pape UF, Pascher A, Ramage J, Reed N, Ruszniewski P, Scoazec JY, Toumpanakis C, Kianmanesh R, Falconi M; Antibes Consensus Conference participants.

Neuroendocrinology. 2017;105(3):255-265. doi: 10.1159/000464292. Epub 2017 Feb 25. No abstract available.

PMID:
28237989
17.

ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation.

Knigge U, Capdevila J, Bartsch DK, Baudin E, Falkerby J, Kianmanesh R, Kos-Kudla B, Niederle B, Nieveen van Dijkum E, O'Toole D, Pascher A, Reed N, Sundin A, Vullierme MP; Antibes Consensus Conference Participants; Antibes Consensus Conference participants.

Neuroendocrinology. 2017;105(3):310-319. doi: 10.1159/000458155. Epub 2017 Feb 17. No abstract available.

18.

"Silent" kidney stones in "asymptomatic" primary hyperparathyroidism-a comparison of multidetector computed tomography and ultrasound.

Selberherr A, Hörmann M, Prager G, Riss P, Scheuba C, Niederle B.

Langenbecks Arch Surg. 2017 Mar;402(2):289-293. doi: 10.1007/s00423-016-1520-2. Epub 2016 Oct 12.

19.

Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis.

Herac M, Niederle B, Raderer M, Krebs M, Kaserer K, Koperek O.

APMIS. 2016 Oct;124(10):839-45. doi: 10.1111/apm.12584. Epub 2016 Aug 19.

PMID:
27539746
20.

Sustained Response to Vemurafenib in a BRAFV600E-Mutated Anaplastic Thyroid Carcinoma Patient.

Prager GW, Koperek O, Mayerhoefer ME, Muellauer L, Wrba F, Niederle B, Zielinski CC, Raderer M.

Thyroid. 2016 Oct;26(10):1515-1516. Epub 2016 Sep 27. No abstract available.

PMID:
27532222

Supplemental Content

Loading ...
Support Center